{"entity":{"id":"cecurio","kind":"institution","name":"CeCurio (MVZ Tübingen oncology)","aka":["MVZ Tübingen"],"tldr":"CeCurio, the oncology and haematology practice of MVZ Tübingen, offers personalised peptide vaccines built with the sequencing laboratory CeGaT, with real-world survival data in glioblastoma.","summary":"The oncology and haematology practice at MVZ Tübingen offers personalised cancer therapy and advanced diagnostics, including personalised peptide vaccines developed in collaboration with CeGaT; Future of Cancer Care Today notes real-world survival data in glioblastoma and lists it as patient-bookable in Germany.","asOf":"2026-09-09","links":[{"label":"Official website","url":"https://mvz-tuebingen.de/en/oncology/"},{"label":"Listed on Future of Cancer Care Today (Sijbrandij Foundation)","url":"https://sijbrandijfoundation.org/fcct"}],"tags":["fcct-directory"],"related":[],"cancers":["glioblastoma"],"sections":[],"technologies":["neoantigen-mrna-vaccine"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"city":"Tübingen","country":"DE","lat":48.52,"lng":9.06,"institutionType":"hospital","website":"https://mvz-tuebingen.de/en/oncology/","programs":[]},"route":"/institutions/cecurio/","neighbours":{"cancer":[{"id":"glioblastoma","kind":"cancer","name":"Glioma & glioblastoma","route":"/cancers/glioblastoma/"}],"technology":[{"id":"neoantigen-mrna-vaccine","kind":"technology","name":"Personalised neoantigen (mRNA) vaccines","route":"/technologies/neoantigen-mrna-vaccine/"}]}}